← Back to Patent Explorer
EP0318446A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Amino acid composition for parenteral nutritional support

Assignee: Vinnars Erik AB
•
Filing: 1988-10-28
•
Granted: —
•
Expires: 2008-10-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a composition for thera­peutic, especially postoperative and posttraumatic, parenteral nutritional support treatment, which compo­sition is based on a conventional amino acid mixture, the composition being characterised in that it also includes L- glutamine and/or alpha-ketoglutarate and optionally L- asparagine, the components of the composi­tion, expressed in g dry component/l aqueous solution, being: glycine (1-12), aspartate (1-10), glutamate (2-12), alanine (2-20), arginine (2-14), cysteine/­cystine (0.4-2.0), histidine (2-8), isoleucine (2-8), leucine (2-8), lysine (2-12), methionine (1-6), phenyl­alanine (4-10), proline (4-10), serine (2-10), threonine (2-8), tryptophan (1-3), tyrosine (0.2-1), valine (2-8), and additionally 5-30 g/l L-glutamine and/or 5-25 g/l alpha-ketoglutarate, and optionally 0.5-10 g/l L-asparagine and/or acetoacetate, or salts or esters thereof. The invention also relates to the use of L-glutamine and/or its derivative alpha-ketoglutarate, and optionally L-asparagine and/or its derivative acetoacetate for the preparation of a composition intended for therapeutic, especially postoperative and posttraumic, parenteral nutritional support treatment, which use is characterised in that L-glutamine and/or alpha-keto­glutarate and optionally L-asparagine and/or acetoace­tate, dissolved in water and sterile-filtered, are added in cold-stored and freeze-dried form or other sterile powder form to a commercial amino acid nutrient solution immediately before the therapeutic treatment.

Inventors

  • 👤 Erik Vinnars

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-26 09:10
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195; A61K31/33; A61K31/395; A61K31/40; A61K31/403; A61K31/404; A61K31/405; A61P; A61P3/00; A61P7/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 63 words
Composition for therapeutic, especially postope­rative and posttraumatic, parenteral nutritional sup­port treatment, which composition is based on a conven­tional amino acid mixture comprising the following components, expressed in g dry component g/l aqueous solution: characterised in that the composition also contains 5-30 g/l L-glutamine and/or 5-25 g/l alpha-ketoglutarate, and optionally 0.5-10 g/l L- asparagine and optionally 0.5-10 g/l acetoacetate, or salts or esters thereof.
Claim 2
Dependent Claim 63 words
Composition for therapeutic, especially postope­rative and posttraumatic, parenteral nutritional sup­port treatment, which composition is based on a conven­tional amino acid mixture comprising the following components, expressed in g dry component g/l aqueous solution: characterised in that the composition also contains 5-30 g/l L-glutamine and/or 5-25 g/l alpha-ketoglutarate, and optionally 0.5-10 g/l L- asparagine and optionally 0.5-10 g/l acetoacetate, or salts or esters thereof.
Claim 3
Dependent Claim 24 words
Composition as claimed in claim 1, cha­racterised in that the amount of L-glutamine or salts or esters thereof is 10-30 g/l, preferably 20 g/l.
Claim 4
Dependent Claim 38 words
Composition as claimed in claim 1, charac­terised in that it contains 5-30 g/l L-glutamine, preferably 10-30g/l and 5-25 g/l alpha-ketoglutarate, preferably 10-25 g/l, and optionally 0.5-10 g/l L-aspara­gine and optionally 0.5-1 g/l acetoacetate or salts or esters thereof.
Claim 5
Dependent Claim 35 words
Composition as claimed in claim 1, charac­terised in that it contains 5-25, preferably 10-25 and most preferably 16.5 g/l alpha-ketoglutarate, and optionally 0.5-10 g/l L-asparagine and optionally 0.5-10 g/l acetoacetate or salts or esters thereof.
Claim 6
Dependent Claim 24 words
Composition as claimed in claim 1, 2, 3 or 4, characterised in that alpha-ketoglutarate is supplied in the form of the sodium salt thereof.
Claim 7
Dependent Claim 28 words
Composition as claimed in claim 1, 2 or 3, characterised in that L-glutamine is supplied in free acid form or in the form of the so­dium salt thereof.
Claim 8
Dependent Claim 52 words
Method for preparing the composition as claimed in the preceding claims, characterised in that L-glutamine and/or alpha-ketoglutarate and optionally L-asparagine and optionally acetoacetate are dissolved in water and sterile-filtered and added, in cold-stored or freeze-dried form or other sterile powder form, to the conventional amino acid mixture immediately before the therapeutic treatment.
Claim 9
Dependent Claim 28 words
The use of the composition as claimed in any one of claims 1-6 for preparing a pharmaceutical pre­paration for therapeutic, especially postoperative and posttraumatic, parenteral nutritional support treatment.

References Cited (Backward Citations)

WO1987003806A1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag